Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Coronary heart disease and COVID-19: A meta-analysis
Journal Information
Vol. 156. Issue 11.
Pages 547-554 (June 2021)
Download PDF
More article options
Vol. 156. Issue 11.
Pages 547-554 (June 2021)
Original article
Coronary heart disease and COVID-19: A meta-analysis
Cardiopatía coronaria y COVID-19: metaanálisis
Chendi Lianga, Weijun Zhangb, Shuzhen Lic, Gang Qinb,
Corresponding author

Corresponding author.
a Shanxi Medical University, Taiyuan, Shanxi, China
b Department of Cardiology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
c Baoan District Center for Disease Control and Prevention, Shenzhen, Guangdong, China
Article information
Full Text
Download PDF
Figures (4)
Show moreShow less
Tables (1)
Table 1. Basic characteristics of the included studies.

Since the World Health Organization (WHO) announced coronavirus disease 2019 (COVID-19) had become a global pandemic on March 11, 2020, the number of infections has been increasing. The purpose of this meta-analysis was to investigate the prognosis of COVID-19 in patients with coronary heart disease.


Pubmed, Embase, and Cochrane Library databases were searched to collect the literature concerning coronary heart disease and COVID-19. The retrieval time was from inception to Nov 20, 2020, using Stata version 14.0 for meta-analysis.


A total of 22,148 patients from 40 studies were included. The meta-analysis revealed that coronary heart disease was associated with poor prognosis of COVID-19 (OR=3.42, 95%CI [2.83, 4.13], P<0.001). After subgroup analysis, coronary heart disease was found to be related to mortality (OR=3.75, 95%CI [2.91, 4.82], P<0.001), severe/critical COVID-19 (OR=3.23, 95%CI [2.19, 4.77], P<0.001), ICU admission (OR=2.25, 95%CI [1.34, 3.79], P=0.002), disease progression (OR=3.01, 95%CI [1.46, 6.22], P=0.003); Meta-regression showed that the association between coronary heart disease and poor prognosis of COVID-19 was affected by hypertension (P=0.004), and subgroup analysis showed that compared with the proportion of hypertension >30% (OR=2.85, 95%CI [2.33, 3.49]), the proportion of hypertension <30% (OR=4.78, 95%CI [3.50, 6.51]) had a higher risk of poor prognosis.


Coronary heart disease is a risk factor for poor prognosis in patients with COVID-19.

Coronary heart disease

Desde que la Organización Mundial de la Salud (OMS) anunció que la enfermedad por coronavirus de 2019 (COVID-19) se había convertido en una pandemia global el 11 de marzo de 2020, se ha incrementado el número de infecciones. El objetivo de este metaanálisis fue investigar el pronóstico de la COVID-19 en pacientes con cardiopatía coronaria.


Se realizó una búsqueda en las bases de datos de Pubmed, Embase y Cochrane Library para reunir la literatura relativa a cardiopatía coronaria y COVID-19. El tiempo de recuperación de datos fue desde el inicio hasta el 20 de noviembre de 2020, utilizando la versión 14.0 de Stata® para el metaanálisis.


Se incluyó un total de 22.148 pacientes de 40 estudios. El metaanálisis reveló que la cardiopatía coronaria estaba asociada a un mal pronóstico de COVID-19 (OR: 3,42; IC 95%: 2,83-4,13; p<0,001). Tras el análisis de subgrupo, se encontró que la cardiopatía coronaria tenía relación con la mortalidad (OR: 3,75; IC 95%: 2,91-4,82; p<0,001), COVID-19 grave/crítica (OR: 3,23; IC 95%: 2,19-4,77; p<0,001), ingreso en la UCI (OR: 2,25; IC 95%: 1,34-3,79; p=0,002), progresión de la enfermedad (OR: 3,01; IC 95%: 1,46-6,22; p=0,003). La metarregresión reflejó que la asociación entre cardiopatía coronaria y mal pronóstico de la COVID-19 estaba influida por la hipertensión (p=0,004), y el análisis de subgrupo mostró que comparada con la proporción de hipertensión >30% (OR: 2,85; IC 95%: 2,33-3,49), la proporción de hipertensión <30% (OR: 4,78; IC 95%: 3,50-6,51) tenía mayor riesgo de mal pronóstico.


La cardiopatía coronaria es un factor de riesgo de mal pronóstico en pacientes con COVID-19.

Palabras clave:
Cardiopatía coronaria


These are the options to access the full texts of the publication Medicina Clínica (English Edition)

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe to

Medicina Clínica (English Edition)

Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
No mostrar más